Jeffrey Tate - Apr 28, 2022 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Operating Officer, Director
Signature
/s/ Jeffrey Tate
Stock symbol
CYTH
Transactions as of
Apr 28, 2022
Transactions value $
$5,279
Form type
4
Date filed
4/29/2022, 03:36 PM
Previous filing
Mar 2, 2022
Next filing
May 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTH Common Stock Purchase $1.59K +635 +2.34% $2.50 27.8K Apr 28, 2022 Direct
transaction CYTH Common Stock Purchase $810 +300 +1.08% $2.70 28.1K Apr 29, 2022 Direct
transaction CYTH Common Stock Purchase $2.88K +1.07K +3.79% $2.71 29.2K Apr 29, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.